Ann: Imugene receives $1.3m R&D Tax Refund-IMU.AX, page-5

The maths is simple to avoid a CR:

1. Get the sp to at least 2c and the oppies will be converted, 371m oppies x 1.5c = about $ 5m

or


2. Get an insto / pharma on board to underwrite oppies even when the sp is sub 1.5c - as far as I know instos are allowed to underwrite and to convert even when heads are lower than conversion price

That would give the insto about 17% ownership after conversion, 371m oppies + 1732m heads ( App 3B, 09 Nov 15).

Anyway, there will be a share consolidation in the future, maybe 1: 10.

But to trigger any of the above actions the Ph2 trials need to start soon and the results need to be mind blowing. The chances for that are very high, lets hope so for all sufferers and us holders.

I hold heaps of oppies ( IMUO, 1.5c, March '17 ) and heads - a failure is not an option.

GLTA